Investors
Strategy
Investment Proposition
First listed REIT offering investors exposure to the UK Life Science sector.
The Theme
- First UK listed REIT focused on the Life Science sector
- Initially focused on Life Science clusters in the “Golden Triangle”
- The UK is at the forefront of life science in Europe, with four of the top ten global research universities, 6,850 businesses and 304,200 jobs
- UK government has set science high on the national agenda, aiming to ensure the UK is a globally recognised hub
- Global leader on VC funding per capita – Cambridge leads the ranking and London and Oxford sit within the top 5
Real Estate Fundamentals
- Life Science real estate includes labs (wet & dry), offices, and manufacturing & prototyping facilities
- Demand-supply imbalance in the “Golden Triangle” is particularly acute for laboratory space
- At 31 December 2023, there was only 2.8% lab space availability in Cambridge
- However, occupier requirements are strong with 1.3m sq ft recorded in the “Golden Triangle” in 2023
- Take-up in the next 10 years is expected to notably exceed pipeline
The Team
- Ironstone Asset Management is the Investment Adviser
- Industry experienced Board
- Leading investment advisory team led by Simon Farnsworth (CBRE GI, GE and Westmount)
- Highly respected and experienced real estate professionals, including several members who have experience in building, operating and growing companies, including a listed REIT backed by strong sectoral trends in the UK
- Excellent relationships with potential vendors, agents, banks, financial institutions and others
ESG
- Global pandemic has focused attention on the Triple Helix1 working to fight disease
- Catalyst for scientific communities by creating buildings conducive to solving global problems
- To reduce the impact on the environment, the Company’s asset management approach will include energy efficiency and reduction programmes, tenant engagement and refurbishing and developing dutifully
- The Company’s success in implementing its ESG strategy will be measured through key performance indicators
Why Now?
- G9 economies are devoting an increasing % of GDP to Life Science – £435bn in 2020 (8.5% increase on 2019)
- Forecast undersupply of Life Science real estate expected to lead to upward pressure on rents
- UK Government’s plans for largest R&D budget: £20.0bn by 2024 – 2025 (+30%)
- Strong growth in the Life Science sector, accelerated by the pandemic, is driving growth in the UK Life Science property sector
- Governments, universities and private companies.